Response to: Correspondence on 'Call for action in ANCA-associated vasculitis and lupus nephritis: promises and challenges of SGLT-2 inhibitors' by Säemann and Kronbichler.

Published in: Annals of the rheumatic diseases (2022)

Keyphrases